A federal appeals court issued a ruling that blocks the prescription of the abortion pills in telehealth appointments and ...
A federal appeals court temporarily reinstated a nationwide requirement that abortion pills be obtained in person, ...
A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking mailing of ...
This Week at FDA: FDA names acting CBER director, House committee advances FDA budget bill, and more
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
By Kamal Choudhury May 1 (Reuters) - The U.S. Food and Drug Administration has named Katherine Szarama as the acting director ...
The FDA names Katherine Szarama, PhD, as acting director of the Center for Biologics Evaluation and Research, succeeding ...
20hOpinion
Moderna Q1 Earnings: Revenue Beat Overshadowed By Litigation Charge, Pipeline Drives Outlook
Moderna (MRNA) beats 1Q26 revenue on international COVID sales, cuts costs, and eyes mRNA-1010 flu PDUFA Aug 5.
Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international marketsReports ...
The company is making up for a decline in U.S. vaccine sales with better results elsewhere, continuing a turnaround that’s ...
Moderna saw its first-quarter revenues nearly triple to $389 million compared to the same period of 2025, with international ...
The ruling is a blow for abortion rights advocates, since it reinstates a requirement that mifepristone — one of the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results